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Abstract
Progressive loss of functional neurons is typically characterized as neurodegen-
eration. This is particularly pronounced during aging and results in debilitating 
conditions such as Parkinson’s disease and Alzheimer’s disease. Symptoms appear 
typically after 70–80% neuronal loss, resulting in irreversible damage. Several 
drugs have been clinically approved but they only alleviate symptoms and addi-
tionally lead to undesirable side effects. Hence there is a dire need for drugs and/
or supplements which address this lacuna. Functional foods are known to offer 
health benefits beyond their attributed nutritional values. Unlike dietary supple-
ments which are made from foods or food-like substances with enriched nutritional 
value, functional foods are foods that are modified for greater nutritional value. 
Conceptually, as an expansion of dietary supplements, functional foods are known 
to be neuroprotective. Here we discuss functional foods which can potentially be 
used as adjunctive therapy, with a note on the regulatory compliance.
Keywords: Neurodegenerative diseases, neuroprotection, functional foods, 
adjunctive therapy, regulatory compliance
1. Introduction
Since 1900 the global average life expectancy has more than doubled and is 
now 70 years. This is expected to further increase over the coming years. This can 
be mainly attributed to better healthcare systems, access to timely medical and 
emergency services, lifestyle changes, decrease in infant mortality, and to a large 
extent higher income. A corollary to this is an increase in the geriatric population, 
which brings with it several age-related health concerns. Not surprisingly, diseases 
of the aging brain are also rampant. The brain is the most privileged organ. Yet, what 
appears to be an advantage could also classify as a drawback as early detection of 
brain disorders always poses to be challenging. Age associated progressive deterio-
ration of the neuronal structures typically results in a group of conditions called 
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Sl No Physiological Effect Food source Phytochemical/ Bioactive compound Regulatory compliance (RC) References
1 Multiomic alterations 1. Green tea
2. Turmeric
1. Butyrate, flavonoids, and 
genistein
2. Caffeine and theanine
3. Curcumin
F, K, P, R, HH [3, 4]














5. Resveratrol Dihydrocaffeic acid, 
malvidin-3′-O-glucoside
6. Folic acid, isothiocyanates, 
docosohexanoic acids
7. Vitamin B12, choline, folate, 
methionine, betaine, biotin, 
pantothenic acid, curcumin
C, D, B, E, F, K, L, M, O, P, S, 
W, AA, GG, HH
[5–13]
3 Mitochondrial health enhancing 1. Red meat, dairy products, avocado, 
chicken, fish, beans
2. Organ meat, muscle meat, fatty fish, 
spinach, cauliflower, broccoli, orange, 
strawberries, sesame seeds and pistachios.
3. Protein rich meats such as beef, turkey, 
pork and limited in chicken
4. cherries, berries, eggs, milk, fish, nuts
1. L-carnitine
2. Co-enzyme Q #
3. Carnosine
4. Green tea catechins
5. Melatonin
C, D, G, H, K, O, P, T, U, R, X, 
Z, HH
[14–18]
4 Anti-inflammatory function 1. Turmeric, Berries, kale, grapes, spinach, 
bell peppers, cocoa, broccoli
2. Soybeans








A, I, K, P, S, U, AA, EE, HH [19–26]
5 Antioxidant function 1. Tea, grapes, lentils, cocoa, apples, apri-
cots, cherries




3. Flavonoids and Alpha-lino-
lenic acid
D, G, J, K, P, S, EE [27–32]
3 D
isease M







Sl No Physiological Effect Food source Phytochemical/ Bioactive compound Regulatory compliance (RC) References







B, G, K, N, P, Q, V, FF [33–38]
7 Neuroprotective role 1. Grape fruit, lemons, oranges







D, K, P, S, V, Y, AA, BB, DD, 
FF, HH
[27, 39–48]






Flavanols B, D, G, K, P, V, EE [49–51]




Trihydroxy-stilbenes B, D, K, P, S, V, CC, EE, FF, HH [52–54]






Flavones D, K, P, S, V, CC, EE [55–57]
A: Belgium-Federal Agency for the Safety of the Food Chain (FASFC); B: Canadian Food Inspection Agency (CFIA); C: Center for Food Safety and Applied Nutrition (CFSAN); D: China-National 
People’s Congress (NPC); E: Council of Europe (Flavouring substances and natural sources of flavouring); F: Dietary Supplement Information Expert Committee (DSIEC); G: European Food Safety 
Authority (EFSA); H: European Medicine Agency (EMA); I: Europe-Center for Food Safety and Applied Nutrition (CFSAN); J:Flax Council of Canada (FCC); K: Food and Drug Administration, USA 
(USFDA); L: Food for Special Dietary Use (FSDU); M:Food Safety and Standards Regulations (FSSR); N: Food Standards Agency, UK (FSA); O: Food Standards Australia New Zealand (FSANZ); 
P: FSSAI- Food Safety and Standards Authority of India; Q; Hong Kong-Centre for Food Safety (CFS); R: International Alliance of Dietary/Food Supplement Associations (IADSA); S: Japan- Ministry 
of Health, Labour and Welfare (MHLW); T: Korean Food and Drug Administration (KFDA); U: Malaysia-Food Safety and Quality Division (FSQD); V: Malaysia-Ministry of Health; W: Medicines 
and Healthcare products Regulatory Agency, UK (MHRA); X: Natural health product (NHP) in Canada; Y: Nepal-Department of Food Technology and Quality Control (DFTQC); Z: NIH- Office 
of Dietary Supplements (NIH-ODS); AA: Norway-Norwegian Ministry of Agriculture and Food (NMAF); BB: Philippines-Food and Drug Administration (PFDA); CC: Portugal-Economic and Food 
Safety Authority (EFSA); DD: South Korea-Ministry of Food and Drug Safety (MFDS); EE: Taiwan FDA (TFDA); FF: UK-Department for Environment, Food, & Rural Affairs (DEFRA); GG: UK-Food 
Standards Agency (FSA); HH: United States Department of Agriculture (USDA).#Not approved by FDA.
Table 1. 
Table depicting a comprehensive list of the various physiological effects exerted by functional foods, their dietary sources, and status of their regulatory compliance.
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neurodegenerative disorders; Alzheimer’s Disease (AD) and Parkinson’s Disease 
(PD) being classical examples. These debilitating disorders negatively impact neuro-
nal functions in a progressive manner. Although age is the predominant risk factor, 
environmental influences play a significant role. Pharmacological and surgical 
approaches are being rampantly used as therapy. While these strategies address the 
clinical symptoms and provide relief to the patients with minimal side effects, they 
fail to prevent disease progression. Further, there could be additional risk involved 
due to chronic drug administration. Owing to these serious lacunae, there is a dire 
need to investigate novel approaches which are disease modifying, neurorestorative, 
possibly curative, and have minimal side effects. Adopting a nutritional approach 
is being increasingly considered for its protective function and has already proven 
effective in several patients. Special diets and a dietary plan have been investigated 
for their neuroprotective roles. Increasing the nutrient value and quality of the diet 
and adherence to the dietary plan are being emphasized for long term benefits.
Foods that we consume have three functions: primary, secondary, and sometimes 
tertiary functions. While the primary function would be to meet the body’s energy 
requirement, the secondary function is attributed to the flavor, smell, appearance, 
texture, etc. In addition, certain foods have been known to modulate human physiol-
ogy and hence prevent disease. This function is sometimes regarded as the tertiary 
attribute and includes anti-carcinogenic, anti-inflammatory, antioxidant, anti-muta-
genic, and anti-ageing, to list a few. Foods that possess such attributes are classified as 
‘functional foods’. Functional foods are known to offer health benefits beyond their 
traditional nutritive values. Physiologically, they help reduce the risk of contracting 
chronic diseases. These are conventional foods which can be consumed like a normal 
diet, but are fortified with a specific or cocktail of well-balanced health promoting 
nutrients. Good examples of such fortified foods are iron-fortified cereal, iodized salt, 
vitamin D-fortified milk etc. Functional foods contain the required amounts of anti-
oxidants, carbohydrates, vitamins, proteins, fats, and other components so as to boost 
the immune system and improve cell survival. Functional foods overlap with nutra-
ceuticals, medical foods, probiotics, designer foods, pharmafoods, and vitafoods. The 
health benefits and physiological effects attributed to functional foods and nutrients 
such as polyphenols are also relevant in the context of brain health but are relatively 
under investigated. Consumption of foods containing natural antioxidants such as 
legumes, fruits, herbs, whole grains, and vegetables, or processed foods enriched 
for natural antioxidants such as vitamin C and E, omega 3-fatty acids, carotenoids, 
polyphenols, stilbenes, etc. can provide the desired protection against neurodegen-
erative and metabolic disorders [1, 2]. Here, we discuss the various biological effects 
modulated by functional foods in the context of neurodegeneration, with a note on 
the regulatory guidelines and regulatory status of such functional foods (Table 1).
2. ‘Omic’ and physiological effects exerted by functional foods
2.1 Multiomics
Advancing technology has made possible the study of entire gene sets or protein 
complements as one unit resulting in the ‘omics’-era. High throughput investiga-
tions allow access to huge amount of data and aid in understanding biology in an 
interactive and holistic manner. Diet offers many health promoting and disease 
preventing factors which target not just one gene/protein/cell type/pathway, but 
can affect multiple entities resulting in a cumulative outcome. The influence of bio-
active food components on the gene expression is termed as ‘nutrigenomics’ and the 
response of gene variants to a particular nutrient is called ‘nutrigenetics’. Nutrients 
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from the diet can interact with the genetic material by functioning as co-factors or 
substrates for processes that regulate DNA metabolism and gene expression. Early 
life exposure to nutrients and environmental factors both during the prenatal and 
postnatal period has a significant influence on gene expression, cellular plasticity, 
and susceptibility to various adult diseases [58].
The first and most widely employed omics technology is transcriptomics which 
is highly efficient and provides high-throughput data. It provides a snapshot into 
the mRNA complement of the tissue at a particular time. It allows us to understand 
the influence of bioactive dietary compounds on gene sets and biological processes. 
Microarray technology offers the possibility of understanding the change in gene 
expression patterns after exposure to a particular nutrient. Using a wide range 
of bioinformatic tools one can build interaction networks and pathway for the 
observed gene profiles [59, 60]. An accumulation of large - scale nutritranscriptomic 
microarray data has necessitated the need for integrated web-based databases which 
have been built on open-source platforms and ensure efficient organization, storage, 
and analysis of the humungous data [61].
The proteome represents the protein complement of the genome that is 
expressed at a particular time in response to a particular stimulus and is more 
complex, dynamic, and subject to spatio-temporal changes. While the genome is 
constant, the expression of the gene is largely dependent on several parameters; 
alternative splicing and post translational modifications included. Protein iden-
tification technologies have largely evolved from simple gel-based techniques to 
mass spectrometry and multiplexed immunoassays which are further assisted by 
powerful bioinformatic tools. Nutritional proteomics hence allows us to examine 
the effect of food components on protein expression and also offers a platform for 
biomarker identification in relation to dietary interventions. In vitro and in vivo 
studies have revealed the impact of dietary component such as butyrate, flavonoids, 
and genistein on the proteome [62–66]. One study identified thirteen candidate 
proteins as potential biomarkers of neuroprotection in response to grape seed 
extract supplementation [67].
Metabolomics is the newest addition to the omics family in nutritional research. 
Metabolome is the complete set of metabolites synthesized as a result of the 
genome-environment interactions under a given environmental condition. Similar 
to the other omics approaches advanced techniques such as mass spectrometry and 
Nuclear Magnetic Resonance (NMR) in addition to powerful bioinformatic tools 
enables us to detect the biochemical changes in response to nutritional interventions 
and also understand the impact of genetically modified foods on food safety [68].
Studies regarding the effect of functional foods with metabolomic effects 
related to neurodegenerative disorders are limited. Green tea and curcumin are 
among those that have been reported to exert metabolome changes. Use of green 
tea polyphenols on aging rats resulted in metabolomic alterations. Dysregulation of 
lipid metabolism was moderated by consumption of caffeine and theanine enriched 
green tea [69]. NMR and MS based metabolomics showed the effect of curcumin on 
hyperlipidaemia mice induced by high-fat diet [70].
2.2 Epigenetics and functional foods
Unlike what was popularly believed a few years ago, somatic heritable states 
need not necessarily depend on the DNA sequence alone. There could be envi-
ronmental influence resulting in DNA methylation, histone modifications, and 
chromatin remodelling. Both external and internal factors could bring about 
such epigenetic changes which can in turn control the gene expression pattern. 
These changes are also heritable and hence provide a framework for the quest 
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of etiological factors governing several diseases including neurodegenerative 
diseases. It is aptly said ‘you are what you eat’. Nutrition and the bioactive food 
components can influence the epigenetic mechanisms and bring about changes at 
the transcriptional level. Vitamin B12, choline, folate, methionine, betaine all of 
which are constituents of the diet, mediate 1-carbon metabolisms involved in DNA 
and histone methylation. Biotin is a substrate for histone biotinylation; niacin and 
pantothenic acid facilitate histone ADP-ribosylation, acetylation, and deacetylation 
processes [71–73]. Several phytochemicals like tea catechins, resveratrol, sulfora-
phane, curcumin, etc. affect epigenetics [74, 75].
Natural products from tea, garlic, soy products, herbs, grapes, and cruciferous 
vegetables have epigenetic targets. Selenium in Brazil nuts, sulforaphane in broccoli, 
epigallocatechin-3-gallate in green tea, resveratrol in grapes, and genistein in soy 
beans have been shown to be dietary inhibitors of DNA methyltransferases [76, 77]. 
While epigenomic alterations owing to dietary interventions are well documented 
in carcinogenesis, their effects in neurodegenerative diseases are limited. Vitamin 
B12, folic acid, dietary polyphenols, isothiocyanates, docosohexanoic acids, olive 
oil, blueberries, fish, and a diet rich in vegetables have been suggested to modify the 
epigenetics of AD [78]. Dihydrocaffeic acid from grape juice and malvidin-3′-O-
glucoside from grape seed extract, reduced proinflammatory cytokines via down-
regulation of DNA methyltransferase 1 and upregulation of histone deacetylase 2 
respectively, hence attenuating depression-like behaviour in mice [79].
2.3 Neuroinflammation and functional foods
Inflammatory processes localized to the central nervous system (CNS) are cat-
egorized as neuroinflammation. It can be regarded as a double edged sword as it is 
deleterious but at the same time triggers the repair and recovery mechanisms.  
Glia, the CNS specific immune cells play a major role in this process. A cross talk 
between the CNS and the inflammatory cells mediates an inflammatory response 
involving the production of mediators such as cytokines, chemokines, reactive oxygen 
species (ROS), and second messengers, by the latter. Recruitment of immune cells, 
edema, tissue damage, and possibly cell death are some events that follow inflamma-
tion. The positive responses of neuroinflammation can involve immune surveillance, 
injury induced remodelling, immune preconditioning, development, memory, and 
learning; all of these leading to tissue repair, neuroprotection, and enhanced plasticity 
[80]. Hence, even though neuroinflammation is one of the most evident consequence 
of neurodegeneration, therapeutic strategies could be evolved so as to potentiate the 
positive effects of inflammation and concomitantly mitigate the negative effects.
Neuroinflammation in the context of AD and dementia were mitigated by 
functional foods. Mediterranean diet such as fruits, vegetables, whole grains, nuts, 
and legumes; moderate intake of fish, poultry, and alcohol; and low intake of red 
and processed meat improved cognitive function in elderly, probably due to the 
anti-inflammatory mechanisms [81]. Dietary components categorized as functional 
foods encompassing carrots, tomatoes, cranberry, grape seeds, papaya, pomegran-
ate, curcumin, ginger, green tea, PUFA, dark chocolates, and cocoa have shown 
antioxidant and anti-inflammatory properties [82].
2.4 Mitochondrial health and functional foods
Mitochondria are the seat of cellular energy metabolism and several key 
housekeeping activities. Neuronal functions are highly energy demanding and the 
presence of healthy mitochondria is indispensable. Several evidences suggest a link 
between dysfunctional mitochondria and neurodegenerative diseases. Mitochondrial 
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glucose metabolism, oxphos enzyme activities, mitochondrial dynamics, motility, 
fusion and fission have all been implicated in neurodegeneration. TCA enzymes such 
as pyruvate dehydrogenase, isocitrate dehydrogenase, and α-ketoglutarate dehydro-
genase, were impaired in post-mortem AD brain and fibroblasts from AD patients 
[83]. Mitochondrial electron transport chain complexes I, III, and IV showed 
reduced activities in platelets and lymphocytes and post-mortem brains from AD 
patients [84, 85]. Additionally, aberrant expression of Drp1, a protein associated 
with mitochondrial dynamics was reported in AD brains, AD mouse models and 
APP cell lines [86]. Likewise, deficiency in mitochondrial complex I in the SNpc of 
the brain, lymphocytes, platelets, and muscle from PD has been well established 
[87]. Several genes related to genetic forms of PD such as phosphatase and tensin 
homolog-induced putative kinase 1 (PINK1), DJ-1, α-synuclein, parkin, and leucine-
rich repeat kinase 2 (LRRK2) are associated with mitochondria. Parkin and PINK1, 
implicated in mitochondrial quality control, mitophagy, and mitochondrial dynam-
ics are reported to be abnormal during PD [88, 89]. Knockout mice for mitochon-
drial transcription factor A (Tfam), associated with mitochondrial copy number, 
maintenance and transcription of mitochondrial DNA, survive to adulthood and 
display Parkinsonian phenotype such as intracellular inclusions within dopaminergic 
neurons, dopaminergic cell degeneration, and loss of striatal dopamine [90, 91]. 
Considering the significant role of mitochondrial health in neuronal function, use 
of functional foods that protect and/or preserve mitochondrial health and in turn 
its function is a promising approach. L-carnitine and co-enzyme Q10 play a key role 
in mitochondrial biogenesis and health. L-carnitine exhibits antioxidant function 
within the mitochondria by scavenging ROS and prevents inflammation. It drives 
ATP production, lowers cholesterol, and helps build lean muscle. Acetyl L-carnitine 
enhances mitochondrial health [92]. Carnitine exerts neuroprotection by acting on 
the NrF2 inhibitor, keap1, and activating the phase II antioxidant system [93]. Unites 
States and Japan are marketing L-carnitine and carnosine fortified foods as energy 
boosting and health promoting products. Green tea catechins have antioxidant 
function and improve cellular energy production and mitochondrial health [94]. 
Melatonin has antioxidant properties and is neuroprotective [95].
2.5 Oxidative stress and functional foods
Increased reactive oxygen species (ROS) can potentially harm cellular macro-
molecules such as lipids, proteins, and nucleic acids. While moderate production of 
ROS is essential for normal cellular function, excess production is countered by a 
battery of antioxidants within the cell. A normal cell maintains this homeostasis but 
if this balance is disturbed a cell experiences oxidative stress. Mitochondria are the 
primary site of ROS production and also its principal target. Increased ROS beyond 
the threshold and/or a failure of the antioxidant defence contributes to mitochon-
drial dysfunction, cellular damage, and oxidative stress contributing to a series of 
events resulting in neurodegeneration. The dopaminergic neurons associated with 
PD are particularly vulnerable to oxidative stress due to their increased iron con-
tent, which catalyzes the Fenton reaction leading to the generation of superoxide. 
Dietary intervention can effectively manage oxidative stress [96–98].
Polyphenols in fruits, vegetables, cereals, dry legumes, chocolate, and tea have 
antioxidant potential and prevent neurodegenerative diseases. Flavonoids from 
fruits and vegetables such as spinach, pepper, asparagus walnut, sunflower seeds, 
and chia seeds have the highest antioxidant capacity [99]. Additionally, α-lipoic 
acid, anthocyanin, Ginkgo biloba, garlic, black cumin, and green tea prevent 
neurodegenerative disorders through antioxidant mechanisms [100]. Black raspber-
ries, rich in the antioxidants anthocyanin and ellagitannin, have successfully been 
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used in clinical trials and are reported to reduce the risk of cancer [101]. Preclinical 
research demonstrated the use of berries in preventing neurodegeneration owing 
to their anthocyanin, caffeic acid, catechin, quercetin, kaempferol, and tannin 
content. They have been shown to reduce oxidative stress, have anti-inflammatory 
function, alter levels of brain–derived neurotrophic factor, and enhance memory 
and cognitive function [42]. However, their clinical uses have not been reported.
2.6 Gut microbiota, neurodegeneration and functional foods
Recent research points to the microbiota-gut-brain-axis as a novel contributing 
factor for neurodegeneration and mood disorders, by directly affecting the neu-
roimmune, neuroendocrine, and direct neural pathways such as the vagus nerve. 
Microbial metabolites which include but not limited to bioactive constituents, 
neurotransmitters, and epigenetic regulators cross the blood–brain-barrier (BBB) 
exerting physiological effects. A dysbiosis in this microbiota causes dysregulated 
gut-brain signalling resulting in oxidative stress, neuroinflammation, immune 
disturbances, and metabolic imbalance [102, 103]. Indeed, altered gut microbiota 
and metabolites like butyrate and amyloid are associated with neurodegeneration 
[104]. The gut of AD patients was shown to have decreased levels of Bacteroidaceae, 
Veillonellaceae, and Lachnospiraceae family members, which contain several key 
butyrate producers, but increased abundance of microbes from Ruminococcaceae, 
Enterococcaceae, and Lactobacillaceae. Pathogenic gut residents such as Escherichia 
coli, Klebsiella pneumoniae, Mycobacterium tuberculosis, Salmonella enterica, 
Salmonella typhimurium, and Staphylococcus aureus, are known to produce amyloid 
proteins, implicated in AD [105]. Stools from patients with Amytrophic Lateral 
Sclerosis (ALS), had increased content of potential inflammatory pathogens such 
as Escherichia coli and members of Ruminococcaceae and Enterobacteriaceae family 
[106, 107]. PD gut showed reduction in the relative abundance of Prevotella, which 
may be associated with reduced metabolism of high-fiber foods, mucin produc-
tion, gut barrier function, and small chain fatty acid (SCFA) levels [108–110]. 
Reduced levels of butyrate producers such as Blautia, Coprococcus, Faecalibacterium, 
and Roseburia species in PD stools suggests increased intestinal permeability and 
inflammation. These observations support emerging evidences of neuroinflamma-
tion in neurodegenerative conditions probably induced by peripheral circulating 
inflammatory products [111].
Considering the role of gut microbiome dysbiosis in neurodegeneration, strate-
gies for modulation of gut microbiota are under investigations. The use of probiot-
ics, synbiotics, and prebiotics either as isolates or herbal supplements appear to be 
promising avenues. Prebiotics are particularly carbohydrates that are selectively 
fermented by gut microbes and modify the microenvironment favourably to the 
microbes and in turn offer health benefits to the host [112, 113]. SCFA such as 
butyrate, of microbial origin are known to modulate histone acetylation pattern and 
inflammatory responses via altered gene expression, induction of T-regulatory cells, 
BDNF expression, and function as signalling molecules between the gut-brain axis 
[114, 115]. Probiotics, contrary to prebiotics, are a cocktail of live intestinal bacteria 
and yeasts which are consumed to improve gut health. They improve the permeabil-
ity of the intestinal wall and the BBB. A randomized, placebo controlled clinical trial 
using pre and probiotics helped improve PD associated bowel dysfunction [116]. In 
the peripheral blood mononuclear cells (PBMC) of PD subjects given probiotics the 
expression of pro-inflammatory cytokines was reduced. Reduced oxidative stress was 
noted in probiotic treated PD subjects as indicated by a decrease in C-reactive protein 
(CRP), malondialdehyde (MDA), and increased glutathione levels [117]. Likewise, 
a double blind placebo controlled clinical trial in AD subjects using probiotic 
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cocktail of Lactobacillus acidophilus, Lactobacillus casei, Bifidobacterium bifidum, and 
Lactobacillus fermentum showed improved learning and memory as scored by Mini 
Mental Score Examination (MMSE) and a reduction in oxidative stress markers such 
MDA levels [118]. Clinical trials using selenium containing probiotics improved the 
MMSE score, antioxidant capacity, reduced serum triglycerides and LDL cholesterol, 
reduced CRP level, and improved insulin sensitivity in AD subjects by altering the 
gut microbial composition [119]. Probiotic Annurca apple puree minimised plasma 
lipid profile and trimethylamine-N-oxide levels, hence offering cardioprotection 
[120]. However, their efficacy in neurodegeneration needs further investigation. 
Likewise, Danone, a French company markets its dairy products enriched with 
Bifidobacterium lactis as a gut health promoting probiotic product [121]. Yet, no stud-
ies exist till date indicating its role in improving brain health. Several studies in in 
vivo models as well as in clinical subjects indicate promising outcome. Nevertheless, 
the use of pre/probiotics as neuroprotective agents is in its infancy as many unan-
swered questions remain. Their therapeutic use is constrained by the absence of 
(1) strong translation of preclinical studies, (2) thorough elucidation of pertinent 
mechanisms, and (3) larger cohort studies.
2.7 Calcium as functional food
Calcium forms a major macronutrient which serves multiple functions in our 
body. Some of them are bone and skeleton formation, coagulation, enzyme func-
tions, nerve conduction, and cardiovascular functions. The source of calcium in 
our body is solely through the diet hence malabsorption or inadequate intake could 
lead to myriad of altered functions in our body. On account of the key physiological 
functions of Calcium, the use of Calcium/Vitamin D supplementation is rampant 
particularly in the elderly and post-menopausal women. Occasionally, regular 
consumption of calcium causes nausea, constipation, and indigestion. Hence, 
consumption of calcium fortified foods is gaining popularity. Examples of calcium 
fortified foods include milk and related products like cheese, yoghurt, and probiot-
ics [122]. Several studies have demonstrated the effect of calcium fortified milk 
and milk products with or without Vitamin D on osteoporosis in the elderly [123]. 
Non-dairy food products rich in calcium are seeds (poppy, sesame, celery and chia 
seeds), edible bones of sardines and salmon, beans and lentils, almonds, and veg-
etables (broccoli, kale, spinach, okra and greens). Although green leafy vegetables 
are rich sources of calcium, their absorption in the gastrointestinal tract depends 
on the presence of inhibitory factors, such as oxalates, phytates, and tannins which 
bind with calcium, rendering it insoluble and therefore unavailable to the body. 
Therefore, the bioavailability of calcium via functional foods is a key factor for 
consideration [124].
3. Regulations of functional foods
The health benefits of food have always been a subject of discussion from 
ancient times. While most initial claims regarding the disease-preventing attributes 
of foods lack scientific evidence, foods such as green tea have been extensively 
investigated for their health promoting role. The modern concept of functional 
foods was born in Asia, and Japan was one of the earliest countries to fund research 
for the systematic analysis and development of functional foods. Research in the 
recent past has clarified that food can be designed not just to meet primary func-
tions, but also to adjust the human body’s homeostasis so as to regulate health 
and wellness. This idea of physiologically relevant functional foods led to the 
Functional Foods
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Sl. No Country Regulatory Policy Governing 
body
Coverage References


















2 Taiwan Health Food Control 
Act (HFCA),














Health Food Control 




3 Hongkong No specific 
regulation on 
nutrient fortified 
foods but referenced 
from the Codex 
Alimentarius, which 
issued a general 
principle for
the ‘Addition of 
Essential Nutrients 
to Foods’ in 1987 
and subsequently 
amended















1. Pharmacy and 
Poisons Ordinance 
(PPO; Cap. 138)
2. Chinese Medicine 
Ordinance (CMO; 
Cap. 549)


















Fats, oils and its 
emulsions,















staple foods i.e. 
vegetable oil, milk, 
salt, rice and wheat 
flour/maida
Food Safety and 
Standards Act, 2006
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formulation of the Japanese regulatory systems. The label and labelling information 
such as the nutrient content or health claims, accompanying the product would 
be a primary determinant of its regulatory status. Thus, if the label claims that the 
Sl. No Country Regulatory Policy Governing 
body
Coverage References
5 Sri Lanka Drug Regulatory 
Authority 
(DRA) or Food 
Administration Unit
Dietary items 
based on the 
traditional wisdom 
of their ancestors 
as treatment for 
certain illness
Food and Nutrition 
Policy of Sri Lanka 
(2004–2010)













improving sleep and 
assisting in memory 
improvement.
Chinese foods and 
traditional Chinese 
medicines
Approved by SFDA 
from July 2003 till 
July 2004
7 USA Food and Drug 
Administration
US government Conventional foods, 
supplemented 
foods, and natural 
health products
The Federal Food, 
Drug, and Cosmetic 
Act (FFDCA)







foods, and natural 
health products








The Korea Health 
Functional Food
Act (HFFA),




2. Nutrition and 
Functional food 
headquarters: 
both under the 
Korean Ministry 




tea, aloe extracts, 





fatty acid and lipids 
(omega-3-fatty 












yeast rice), amino 
acids and proteins 
(soy proteins), aloe 
gel, chitosan etc.
The Presidential 
Decree issued in 
2003, Ministerial 
Ordinance issued in 
2004
Table 2. 
Table depicts a list of the countries along with their functional food regulatory acts.
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product is intended for use in diagnosis, cure, mitigation, treatment, or prevention 
of a disease, it would be regulated as a ‘drug’. However, if the claim relates to any 
alteration of the structure and function of the body, with no specific reference to a 
disease it would be regulated as a dietary supplement [125].
One of the earliest regulatory guidelines was established by the Ministry of 
Health and Welfare in Japan under a policy termed ‘Food for Specified Health 
Use (FOSHU), under which health claims for few selected functional foods 
was made legal (The Nutrition Improvement Law Enforcement Regulations, 
(1996)). The repertoire of functional foods has now expanded to include over 
800 FOSHU products [92]. Following the Japanese example several countries 
have scripted regulatory guidelines for the health enhancing claims of functional 
foods and nutraceuticals. Nevertheless, regulations for functional foods have not 
been well established in most countries. Also, the legislations widely vary from 
country to country.
In the Indian context, the Food Safety and Standards Authority of India (FSSAI) 
under the Ministry of Health and Family Welfare, Government of India, has framed 
the guidelines and regulations for health supplements, nutraceuticals, foods for 
special dietary use, foods for special medicinal purpose, functional foods and, novel 
foods. The quality requirements and general monograph for such foods are defined 
in the Indian Pharmacopoeia, which provides guidelines on the usage of food 
coloring agents, flavours, quantity of nutrients to be added as per Indian Council 
of Medical Research (ICMR) recommended daily allowance. Interestingly, FSSAI 
clarifies that mere foods such as vegetables, fruits, cereals, legumes, spices, and 
other plant or botanicals with minimal processing such as cleaning, de-husking, 
de-weeding, sorting, drying, or powdering, cannot be considered as ‘health supple-
ment’, ‘nutraceutical’, ‘food with special dietary use’, or ‘food for special medical 
use’. However, the formulation of articles of food must be based on the principles of 
medicine of nutrition and must be supported by validated scientific data, wherever 
applicable. More importantly, the label and or leaflet must specify details including 
the specific use, intended target consumers, the physiological or disease conditions 
which they address, recommended duration of usage etc. [126].
A list of the countries along with their regulatory acts has been provided in 
Table 2.
4. Conclusion
Age related neurodegenerative disorders pose a serious healthcare challenge to 
the medical fraternity worldwide. This is a cause for concern, particularly because 
symptoms are evident largely during advanced stages of the disease. Presently 
available monotherapy and pharmacotherapy only provide symptomatic relief. 
Hence there is an urgent need for improved therapeutic approaches. Also, currently 
available pharmaceuticals are not free from adverse effects. Therefore, the world is 
now embracing natural sources as health promoting and disease modifying agents. 
Towards this objective, the use of nutraceuticals and functional foods is on the rise 
(Figure 1). While several scientific reports prove their neuroprotective functions, 
extensive clinical validations are lacking. Further, while some functional foods and 
foods for medical purposes have been evaluated by preclinical and clinical studies, 
the regulatory guidelines for their labelling and use are still evolving. Increasing 
awareness among consumers has brought the functional food market to the fore-
front. It is hence inevitable for authorities to formulate regulatory guidelines with 
respect to their labelling and usage. While some countries worldwide have put forth 
13
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legal guidelines, many more are lagging. In addition, a unified set of guidelines 
across nations is absent.
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Figure 1. 
Neurodegeneration, Physiological Effects, and Functional foods. Image indicates the various physiological 
dysregulations observed during neurodegeneration (outer circle) and an illustration of functional foods which 
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